KRM Ayurveda Limited (KRMAYURVED)
சுருக்கம்
The board meets on 13 Nov 2026 to consider the Q2 FY27 results.
பங்குச் சந்தை செயல்பாடு12 நவ. 2026
- டெலிவரி
- 87.83% எதிர் சராசரி 68.94%
- வால்யூம் அதன் சராசரியுடன் ஒப்பீடு
- 0.8×
நிகழ்வுகள்
- அடுத்த முடிவுகள்
- 13 நவ. 2026 (Q2 FY27)
- சமீபத்திய முடிவுகள்
- Q1 FY27, தாக்கல் செய்யப்பட்டது 28 அக். 2026
- இயக்குநர் குழுக் கூட்ட அறிவிப்பு
- 3 செப். 2026
பங்குச் சந்தைத் தரவு. ஒவ்வொரு எண்ணும் அதன் சொந்தப் பக்கம் காட்டும் வடிவத்திலேயே; தேதிகள் தரவின் தேதிகள். தகவலுக்கு மட்டுமே, முதலீட்டு ஆலோசனை அல்ல.
📈 பங்கு விலை & நிகழ்வுகள்
Q2 FY27 முடிவுகள்
📅 அடுத்த நிதி முடிவுகள்: 13 நவ. 2026 (இயக்குநர் குழுக் கூட்டம்)KRM Ayurveda Limited-இன் இயக்குநர் குழுக் கூட்டம் 13 நவ. 2026 அன்று நடைபெறுகிறது; அதில் அதன் Q2 FY27 முடிவுகள் பரிசீலிக்கப்படும் (ஜூலை-செப்டம்பர் 2026).
In its latest reported quarter, Q1 FY27, KRM Ayurveda's revenue was ₹32.3 Cr, and net profit ₹9.1 Cr; the operating margin was 37.2%.
| Q1 FY27 (₹ கோடி) | மதிப்பு | YoY | QoQ |
|---|---|---|---|
| வருவாய் | ₹32.3 | — | +0.3% |
| செயல்பாட்டு லாபம் | ₹12.0 | — | +9.5% |
| நிகர லாபம் | ₹9.1 | — | +16.3% |
| EPS (₹) | 4.27 | — | +16.3% |
| செயல்பாட்டு லாப வரம்பு | 37.2% | — | — |
KRMAYURVED டெலிவரி சதவீதம்
க்கான NSE EOD தரவு
On Thu, 12 Nov 2026, 87.83% of the KRMAYURVED shares traded on NSE were taken to delivery, against the stock's own 20-session average of 68.94%. The price fell 1.37% on that unusually high delivery, the pattern the delivery dashboard labels distribution.
கடந்த 5 அமர்வுகளில் டெலிவரி: 83.6% · 75.6% · 53.3% · 60.5% · 87.8%
பங்குச் சந்தை வெளியிட்டவற்றின் விளக்கம், பரிந்துரை அல்ல. "accumulation" அல்லது "லாங் பில்டப்" போன்ற பெயர்கள் எண்களில் உள்ள ஒரு வடிவத்தை குறிக்கின்றன. டெலிவரி எவ்வாறு பகுப்பாய்வு செய்யப்படுகிறது
📢 சமீபத்திய கார்ப்பரேட் அறிவிப்புகள்
KRM Ayurveda Limited has announced the establishment of a new day care center under the name 'Karma Ayurveda' in Ghaziabad, Uttar Pradesh. The facility spans approximately 3,000 sq. ft. and has been secured on a 9-year lease period. The center commenced operations retroactively on September 23, 2026. Financial metrics such as capex, expected revenue, and operational capacity were not disclosed.
- New day care center established at Nehru Nagar, Ghaziabad, Uttar Pradesh
- Facility spans approximately 3,000 sq. ft.
- Secured on a lease period of 9 years
- Operations commenced on 23 September, 2026
KRM Ayurveda Limited announced the voting results and Scrutinizer's Report for its Annual General Meeting held on September 30, 2026. All six proposed resolutions were approved by shareholders with 100% of the polled votes cast in favour. Key items passed include the adoption of financial statements, re-appointment and remuneration approval for Managing Director Puneet Dhawan, related party transactions, and the adjustment/utilization of balance IPO proceeds towards general corporate purposes.
- All 6 resolutions passed with 100% votes in favour of valid votes polled
- Total voting participation stood at 1,53,49,300 votes (72.19% of outstanding 2,12,60,800 shares) for general resolutions
- Resolution 4 (Related Party Transactions) saw interested promoter shares excluded, passing with 5,96,400 non-institutional votes in favour
- Special resolution passed approving variation/adjustment and deployment of balance IPO proceeds towards general corporate purposes
KRM Ayurveda Limited has received accreditation from the National Accreditation Board for Hospitals & Healthcare Providers (NABH) for its Panchakarma day care centre located in Dwarka, New Delhi. The certification (Certification No. PC-2026-0170) is valid up to August 20, 2029. The accreditation follows an assessment of the facility's clinical practices, infrastructure, and operational quality management. No financial figures or capacity metrics were disclosed in the intimation.
- Received NABH accreditation for Panchakarma day care centre at Dwarka, New Delhi
- Certification No. PC-2026-0170 awarded to the facility
- Accreditation is valid up to August 20, 2029
- Covers facility located at B-254, Sector 8, Dwarka, New Delhi - 110077
KRM Ayurveda Limited concluded its 7th Annual General Meeting on September 30, 2026. Shareholders approved all agenda items, notably including a special resolution for the variation/adjustment in utilization of IPO proceeds toward General Corporate Purposes. Other approvals included the adoption of FY26 financial statements, MD remuneration, and related-party transactions. The company noted that secretarial auditors gave a qualified audit opinion, while statutory auditors issued an unmodified report.
- 7th Annual General Meeting held and concluded on September 30, 2026
- Special resolution passed approving variation in IPO proceeds utilization towards General Corporate Purposes
- Secretarial auditors issued a qualified opinion for the financial year ended March 31, 2026
- Remote e-voting was open from September 25, 2026 to September 29, 2026
KRM Ayurveda Limited has established a new day care center under the 'Karma Ayurveda' unit in Vashi, Navi Mumbai. The facility covers an area of 2,100 sq. ft. and has been secured on a 5-year lease basis. Operations at this location commenced on September 3, 2026. Financial metrics and investment outlays for this setup were not disclosed in the filing.
- Established a new day care center covering 2,100 sq. ft. in Sector-17, Vashi, Navi Mumbai
- Center secured on a lease tenure of 5 years
- Operations at the new center commenced on September 3, 2026
- Center set up under the 'Karma Ayurveda' unit of the company
KRM Ayurveda Limited has issued the notice for its 7th Annual General Meeting scheduled for September 30, 2026, via video conferencing. Key special business items include fixing the remuneration limit of Managing Director Puneet Dhawan at up to ₹1.44 crore per annum. The company is also seeking shareholder approval for material related party transactions, including up to ₹25 crore with Karma Life Care LLC and ₹15 crore with Karma Online Services LLC. Additionally, approval is sought for a ₹0.20 crore reallocation of IPO proceeds to fund higher issue-related expenses of ₹11.77 crore (up from ₹11.57 crore) by reducing general corporate purposes to ₹9.79 crore.
- 7th Annual General Meeting scheduled for September 30, 2026, at 12:30 PM IST via VC/OAVM.
- Proposed MD remuneration cap for Puneet Dhawan of up to ₹1.44 crore p.a. for FY2026-27.
- Seeking approval for significant Related Party Transactions, including sales of up to ₹25.00 crore to Karma Life Care LLC and ₹15.00 crore to Karma Online Services LLC.
- Proposed reallocation of ₹0.20 crore within ₹77.49 crore total IPO proceeds to meet actual issue expenses of ₹11.77 crore.
KRM Ayurveda Limited has appointed Sachin Kumar Sharma as its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective September 7, 2026. Mr. Sharma holds around 12 years of experience in finance, accounting, financial reporting, audit, and regulatory compliance. The appointment was made in compliance with Regulation 30 of the SEBI LODR Regulations.
- Sachin Kumar Sharma appointed as Chief Financial Officer effective September 7, 2026
- Appointee brings around 12 years of experience in corporate finance, audit, and controllership
- Consent letter submitted under Section 203 & 2(51) of the Companies Act, 2013 on September 3, 2026
KRM Ayurveda Limited announced the resignation of Chief Financial Officer Mr. Avtar Singh Rana, effective September 6, 2026. The Board has appointed Mr. Sachin Kumar Sharma as the new CFO effective September 7, 2026. Additionally, the company's 7th Annual General Meeting is scheduled for September 30, 2026, with a voting cut-off date of September 23, 2026. The Board also approved the Directors' Report for FY26 and appointed M/s Amit K Mangla & Company as the Secretarial Auditor for FY 2026-2027.
- CFO Mr. Avtar Singh Rana resigned effective September 6, 2026
- Mr. Sachin Kumar Sharma appointed as Chief Financial Officer effective September 7, 2026
- 7th Annual General Meeting scheduled for September 30, 2026 at 12:30 PM IST via VC/OAVM
- Cut-off date for e-voting eligibility set for September 23, 2026
KRM Ayurveda Limited has announced the resignation of its Chief Financial Officer (KMP), Mr. Avtar Singh Rana. The resignation was tendered on August 31, 2026, citing personal reasons, and will take effect from September 6, 2026. The outgoing CFO confirmed that there are no other material reasons for his departure.
- Resignation tendered by CFO Mr. Avtar Singh Rana on August 31, 2026
- Effective date of cessation is September 6, 2026
- Reason cited as personal reasons with confirmation of no other material reasons
KRM Ayurveda reported a strong Q1 FY27 with total income rising 32.4% YoY to ₹32.87 cr. Net profit surged 124.2% YoY to ₹9.08 cr, driven by significant margin expansion with EBITDA margins reaching 38.22% (+1,257 bps YoY). The services segment (hospitals) was the primary driver, growing 109.8% YoY, while the company added 103 beds in FY27 YTD. Management expects these new beds to generate ₹25 cr in incremental annualised revenue.
- Net Profit (PAT) increased 124.2% YoY to ₹908.45 Lakhs in Q1 FY27
- EBITDA margins expanded by 1,257 bps YoY and 372 bps QoQ to 38.22%
- Added 103 beds in FY27 YTD with an estimated annualised revenue potential of ₹25 cr
- Services revenue grew 109.8% YoY to ₹2,392.20 Lakhs, offsetting a decline in product revenue
- Digital reach includes 8 lakh+ YouTube followers to support the Q2 FY27 D2C platform launch
KRM Ayurveda reported a robust performance for Q1 FY27, with revenue from operations growing 31% YoY to ₹32.32 crore. Net profit more than doubled to ₹9.08 crore from ₹4.05 crore in the year-ago period, driven by significant operating leverage as total expenses grew only 6.4% YoY. The company, listed on the NSE SME platform, voluntarily disclosed these quarterly results despite only being required to report half-yearly. Working capital remains strong at ₹81.27 crore, supported by ₹15.12 crore in unutilized IPO proceeds currently parked in fixed deposits.
- Revenue from operations increased 31% YoY to ₹32.32 crore from ₹24.67 crore.
- Net profit surged 124% YoY to ₹9.08 crore, up from ₹4.05 crore in June 2025.
- Profit Before Tax (PBT) margin improved to 37.2% in Q1 FY27 from 21.8% in Q1 FY26.
- Total expenses were contained at ₹20.63 crore, representing a modest 6.4% increase despite the 31% revenue jump.
- Unutilized IPO proceeds of ₹15.12 crore are currently held in earmarked fixed deposits for future expansion/needs.
KRM Ayurveda Limited has acquired 100% of the equity share capital of Karma Nutravedics Private Limited for a total cash consideration of ₹1,00,000. The target company, incorporated in August 2023, has not yet commenced commercial operations and reported zero turnover for the last three financial years. This acquisition, effective July 3, 2026, establishes a dedicated wholly-owned subsidiary for the company's nutraceuticals and health supplements vertical. Management indicates the transaction is not material relative to the company's current turnover or net worth.
- Acquisition of 10,000 equity shares at a face value of ₹10 each, totaling ₹1,00,000.
- Target company Karma Nutravedics reported Nil turnover for FY24, FY25, and FY26.
- The transaction was completed on July 3, 2026, making it a Wholly Owned Subsidiary.
- The acquisition is intended to ring-fence the nutraceuticals and wellness vertical for focused management.
KRM Ayurveda Limited has submitted detailed clarifications to the NSE regarding its financial results for the year ended March 31, 2026. The company reported a Net Working Capital of ₹8,735.45 Lakhs, supported by ₹9,416.73 Lakhs in current assets. Crucially, the filing details the utilization of IPO proceeds, with ₹2,227.7 Lakhs deployed for working capital in FY26 and ₹3,304.5 Lakhs currently held in fixed deposits for other earmarked purposes. The statutory auditor has issued an unmodified opinion, confirming no major accounting discrepancies.
- Net Working Capital reported at ₹8,735.45 Lakhs as of March 31, 2026
- ₹2,227.7 Lakhs of IPO proceeds utilized for working capital requirements during FY 2025-26
- ₹3,304.5 Lakhs from IPO proceeds earmarked in fixed deposits for non-working capital purposes
- Total Current Assets stood at ₹9,416.73 Lakhs against Current Liabilities of ₹681.28 Lakhs
- Statutory Auditor Shiv & Associates issued an Unmodified (Unqualified) Audit Opinion
நிறுவனச் சுயவிவரம்
நிதிச் செயல்திறன்
இந்த நிறுவனத்துக்கான நிதிப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
செயல்பாட்டு உந்துசக்திகள்
இந்த நிறுவனத்திற்கான செயல்பாட்டுப் பகுப்பாய்வுத் தரவு இன்னும் கிடைக்கவில்லை.
வியூக வளர்ச்சி
இந்த நிறுவனத்துக்கான வியூக வளர்ச்சிப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
வெளிப்புறக் காரணிகள்
இந்த நிறுவனத்துக்கு வெளிப்புறக் காரணிகளின் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
ஒழுங்குமுறை & நிர்வாகம்
இந்த நிறுவனத்திற்கான ஒழுங்குமுறைப் பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
அபாயப் பகுப்பாய்வு
இந்நிறுவனத்துக்கான அபாய பகுப்பாய்வு இன்னும் கிடைக்கவில்லை.
